跳至主要内容
临床试验/CTRI/2021/01/030262
CTRI/2021/01/030262招募中4 期

A multicentric, open labelled, non-comparative, single dose observational study to assess the local tolerability of Diclofenac AQ Injection(DiclofenacSodium 75 mg/ml injection manufactured by Akums Drugs andPharmaceuticals Ltd., India.) upon Intramuscular administration in patients having severe inflammatory orspasmodic pain

Akums Drugs and Pharmaceuticals Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. Patients having severe inflammatory or spasmodic pain with VAS score up to 7 (mild to moderate pain) and requiring immediate relief.
  • 2. Patients who are able to and willing to provide written informed consent

排除标准

  • 1. Hypersensitivity to the drug components or other drug from same class
  • 2. Patient unable to refrain from alcohol, psychoactive drugs, and sedatives including sleeping preparations (eg benzodiazepines) for the duration of their participation in the study
  • 3. Patient with history of drug of abuse
  • 4. Patients recently diagnosed any viral or bacterial infection

研究者

相似试验